Mentor Capital, Inc. (Pink Sheets:MNTR) reports that its proprietary
Cancer Immunotherapy Index appreciated 30.6% during the first half of
2013. The equally weighted Cancer Immunotherapy Index is regularly
benchmarked against the appreciation of the average of the NASDAQ, S&P,
and NYSE Biotech Indices. For the first half the biotech indices
averaged a 34.5% gain.
Galena (45%), Inovio (59%) and Celldex (133%) have led the sector in
gains during the January through June 2013 period. Dendreon ($650
Million), Celldex ($1,262 Million) and NewLink Genetics ($392 Million)
represent 66% of the market capitalization of the fifteen member Cancer
Immunotherapy Index which has a combined total share value of $3.5
Billion.
The Mentor Capital Cancer Immunotherapy Index companies and their
performance for the first twenty-six weeks of 2013 follow: Galena
Biopharma Corporation (NASDAQ:GALE) +45.10%, NewLink Genetics
Corporation (NASDAQ:NLNK) +22.40%, Vical Incorporated (NASDAQ:VICL)
+7.56%, Inovio Pharmaceuticals, Inc. (NYSEMKT:INO) +59.36%, Dendreon
(NASDAQ:DNDN) -22.12%, Immunocellular Therapeutics, Ltd. (NYSE MKT:IMUC)
+1.04%, Agenus (NASDAQ:AGEN) -7.56%, Oncothyreon (NASDAQ:ONTY) -18.23%,
Biovest International (OTCMKTS:BVTIQ) -84.80%, Celldex Therapeutics
(NASDAQ:CLDX) +132.64%, Northwest Biotherapeutics (NASDAQ:NWBO) +7.07%,
CEL – SCI Corp. (NYSEMKT:CVM) -21.11% , Generex Biotechnology
(OTCBB:GNBT) +32.00% as a proxy for its wholly-owned immunotherapeutic
subsidiary, Antigen Express, Provectus Pharmaceuticals, Inc.
(OTCMKTS:PVCT) +14.29% and Advaxis, Inc. (OTCBB:ADXSD) +34.67% - all for
an average 2013 YTD gain of +30.60%. (Annualized rate: +61.20%).
Mentor Capital, Inc., by acquisition or stock purchase, seeks to invest
in leading-edge private and public cancer companies, and certain other
situations. Mentor created the Cancer Immunotherapy Index July 10, 2009.
Since then, it has invested or maintained a tracking position in all
companies in the Cancer Immunotherapy Index which can be found at www.MentorCapital.com.
Forward Looking Statements, Safe Harbor and Risk Descriptions are
Incorporated by Reference from the MNTR Company Web Site above.
Copyright Business Wire 2013